Windhover.com | Medtech Insight | The RPM Report | Inteleos | EBI
Subscriber Username:   Password: Forgot Password?
Health Care Business Intelligence, Analysis, Insight - Windhover
Search


Receive Windhover's unique market insight fast with our free alert service 'Windhover's Update', including the latest abstracts and summaries from:

• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight


Sign up now

Since 1989, Windhover Information Inc. has been providing superior analysis and commentary on health care business strategy, industry dealmaking, marketplace trends, and the world of medical start-ups. The expertise that our editorial and research staff have developed--now consulted and relied upon by the industry's top executives, consultants, bankers and investors--finds voice in our publications, leading-edge conferences, and integrated, highly searchable databases of transactions and commentary. Windhover's editorial goal: to clearly present objective, accurate, fundamentally valuable decision-making information.

In March 2008, Windhover Information Inc. was acquired by Elsevier, the world’s leading publisher of science, technical and health information. In combining Windhover's analysis and commentary on business strategy, deal-making, and market trends, with the extensive and timely regulatory and reimbursement coverage of Elsevier's F-D-C Reports, we have built a comprehensive and interoperable source of information that biopharma and medical device professionals can rely upon to make critical business decisions.  Elsevier Business Intelligence is the name under which we will now be offering our full-line of products and services. For more information on this acquistion, view the press release here.

How we generate our content:

Windhover has amassed an unparalleled number of personal contacts at most companies in the pharmaceutical, biotech, medical device and diagnostic industries as well as in the investment banking, venture capital, consulting and other industry-support sectors. Our editorial and research staff leverages this extensive contact list in primary research, which we supplement with an extensive scanning, understanding and use of company and SEC documents. But whereas other information providers merely parrot back what they learn, Windhover's editors and writers use their extensive expertise in the industry to draw out the significance of the data, presenting not merely the facts but what we call the "so what" of trends, events, and strategies.

Related websites of interest:

Windhover Online (Subscribers) - sis.windhover.com
The RPM Report - www.rpmreport.com
Medtech Insight - www.medtechinsight.com
Company Profiles - companies.windhover.com
The IN VIVO Blog - invivoblog.blogspot.com
Elsevier - www.elsevier.com
FDC Reports - www.fdcreports.com


The IN VIVO Blog

BIOWindhover/Pharmaceutical Strategic Outlook
February 23-25, 2010 · New York, NY

IN3 West + Investor Day
March 3-5, 2010 · Las Vegas, NV

IN3 Europe + Investor Day
April 28-30, 2010 · Paris, France

Interested in presenting at a Windhover conference?
Submit your idea here


Biopharma Trends: Nowhere To Go But Up
Biopharmaceutical trends in 2008 were fundamentally altered by the global financial crisis. And 2009's events were similarly impacted by the ongoing recovery. . . [MORE] (IN VIVO)

The A-List: 2009's Trend-Shaping Series A Financings
New company creation slipped significantly in 2009 as venture capitalists conserved capital and supported existing portfolio companies. . . [MORE] (Start-Up)

Stent Market Doldrums Push Interest Elsewhere
The new realities of the drug-eluting stent market are evident in recent sales results from the big competitors, driving many of them to branch into other higher growth areas. . . [MORE] (Medtech Insight)

The Future of Pharma: The Scale to Fail
The pharmaceutical sector saw a wave of major consolidation in 2009. There are a number of lessons to be learned from the M&A activity that can be applied to the New Year, including the increasing need to get bigger in order to absorb the R&D misses. . . [MORE] (The RPM Report)

Read more from the latest: IN VIVO, Start-Up, The RPM Report, Medtech Insight, "The Pink Sheet", "The Pink Sheet" DAILY, "The Rose Sheet", "The Tan Sheet", PharmAsia News, Pharmaceutical Approvals Monthly, and "The Gray Sheet".




Pharma Deals
  FDA Has Full Plate This Fall for Vaccines: More Than H1N1
  GSK Slides Away From Innovation
  The Billion Dollar REMS: Xenazine?
Device Deals
  Stroke Devices: Facing Challenges Head On
  Vascular Closure Devices at the Crossroads
  What New Her2 Tests Say about Personalized Medicine

Interested in subscribing? Click here.
Publications - Databases - Conferences - About Us - Contact Us - Help - The IN VIVO Blog - Company Profiles - Subscriber Login

Copyright © 2010, Windhover Information, Inc. An Elsevier company. All rights reserved.

Elsevier Business Intelligence